Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ranson

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1S J Danson, P Johnson, T H Ward, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 17, 2023
Artificial intelligence for dementia drug discovery and trials optimizationThomas Doherty, Zhi Yao, Ahmad A L Khleifat, et al.
British Journal of Cancer|October 29, 2009
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II studyR E Board, G Ellison, M C M Orr, et al.
British Journal of Cancer|April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaR F Kefford, N P B Thomas, P G Corrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor typesJ Baselga, D Rischin, M Ranson, et al.
JAMA Neurology|November 11, 2024
Frailty Trajectories Preceding Dementia in the US and UKDavid D Ward, Jonny P Flint, Thomas J Littlejohns, et al.
Arxiv|March 13, 2023
Artificial Intelligence for Dementia Research Methods OptimizationMagda Bucholc, Charlotte James, Ahmad Al Khleifat, et al.
Brain Informatics|February 24, 2023
Harnessing the potential of machine learning and artificial intelligence for dementia researchJanice M Ranson, Magda Bucholc, Donald Lyall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2023
Artificial intelligence for dementia research methods optimizationMagda Bucholc, Charlotte James, Ahmad Al Khleifat, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1S J Danson, P Johnson, T H Ward, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 17, 2023
Artificial intelligence for dementia drug discovery and trials optimizationThomas Doherty, Zhi Yao, Ahmad A L Khleifat, et al.
British Journal of Cancer|October 29, 2009
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II studyR E Board, G Ellison, M C M Orr, et al.
British Journal of Cancer|April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaR F Kefford, N P B Thomas, P G Corrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor typesJ Baselga, D Rischin, M Ranson, et al.
JAMA Neurology|November 11, 2024
Frailty Trajectories Preceding Dementia in the US and UKDavid D Ward, Jonny P Flint, Thomas J Littlejohns, et al.
Arxiv|March 13, 2023
Artificial Intelligence for Dementia Research Methods OptimizationMagda Bucholc, Charlotte James, Ahmad Al Khleifat, et al.
Brain Informatics|February 24, 2023
Harnessing the potential of machine learning and artificial intelligence for dementia researchJanice M Ranson, Magda Bucholc, Donald Lyall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2023
Artificial intelligence for dementia research methods optimizationMagda Bucholc, Charlotte James, Ahmad Al Khleifat, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
Pageof 16